03.21.24 -- The Impact Of Automation And AI On Gene Therapy

Demand for single-use production tools, components, expertise, and capabilities grows as cell therapies evolve. However, concerns and misconceptions remain about single-use solutions.

Using information from user requirement specifications and other documents, this article suggests companies may benefit from a risk-based approach to calibration.

Explore how drug-resistant strains are posing challenges when it comes to the treatment of candidiasis, but therapeutic advancements and ongoing research are offering hope for improved outcomes.

Depth of management typically is less about ensuring your trial progresses smoothly and more about hiding the CRO’s deficiencies or appeasing its own stakeholders.

Here, we discuss the characterization of several representative AAV molecules using next-generation sequencing (NGS), including the sequencing process, bioinformatic analysis, and representative results.

Achieve a more physiologically relevant setting with less reliance on model animals when studying diseases like cancer through the combination of CRISPR screening and bulk spheroid production.

Uncover a holistic approach to streamline the change control process, which aims to increase efficiency and compliance, improve quality, and shorten time-to-market.

The clonality of master cell banks (MCBs) for production cell lines is a key requirement in biotherapeutics manufacturing. Learn how new devices help optimize the cloning process.

Discover how Veristat’s full-service clinical trial team helped tightly coordinate a gene therapy's dosing administration and data review.

Genomic medicine provides an excellent prospect for faster drug development. See how optimizing LNPs can help overcome drug-delivery challenges, unlocking potential new genomic medicines faster.

Amidst the shift toward decentralized manufacturing models, consider an approach that allows for standardized processes, remote monitoring and control, and centralized quality oversight.